Vast Therapeutics Awarded Another $2 Million Grant to Combat Rare Respiratory Disease
Funds from NIH will Advance Orphan Drug Development as a Potential Treatment for Non-tuberculous Mycobacteria Pulmonary Disease MORRISVILLE, NC, UNITED STATES, September 16, 2025 /EINPresswire.com/ -- Vast Therapeutics, a clinical-stage life science …